YARA CABRERA: Open Payments
NPI 1487154316 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 35 payments from 15 companies in 2025. Trend: 2023 $1,445 · 2024 $928 · 2025 $902
Food & beverage: $803Education: $99
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $229 |
| 180 Medical, Inc. | 4 | $138 |
| Janssen Biotech, Inc. | 2 | $130 |
| PFIZER INC. | 5 | $115 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $48 |
| ABBVIE INC. | 2 | $34 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $34 |
| Endo USA, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Blue Earth Diagnostics | 1 | $25 |
Products named: ORGOVYX, ERLEADA, XTANDI, GENTLECATH, GEMTESA, PYLARIFY, LUPRON DEPOT, Bard Urinary Drainage Bag.
Industry payments across FL — which companies pay providers there.
